A
Axel Baumgarten
Researcher at Praxis
Publications - 76
Citations - 1471
Axel Baumgarten is an academic researcher from Praxis. The author has contributed to research in topics: Hepatitis C & Ribavirin. The author has an hindex of 17, co-authored 70 publications receiving 1207 citations.
Papers
More filters
Journal ArticleDOI
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
Susan Swindells,Jaime-Federico Andrade-Villanueva,Gary Richmond,Giuliano Rizzardini,Axel Baumgarten,Mar Masiá,Gulam H Latiff,Vadim Pokrovsky,Fritz Bredeek,Graham H R Smith,Pedro Cahn,Yeon Sook Kim,Susan L. Ford,Christine L. Talarico,Parul Patel,Vasiliki Chounta,Herta Crauwels,Wim Louis Julien Parys,Simon Vanveggel,Joseph M. Mrus,Jenny Huang,Conn M. Harrington,Krischan J Hudson,David A. Margolis,Kimberly Y. Smith,Peter Williams,William Spreen +26 more
TL;DR: In this paper, simplified regimens for the treatment of human immunodeficiency virus type 1 (HIV-1) infection may increase patient satisfaction and facilitate adherence, which may improve adherence.
Journal ArticleDOI
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe
Patrick Ingiliz,Thomas C S Martin,Alison Rodger,Hans-Jürgen Stellbrink,Stefan Mauss,Christoph Boesecke,Mattias Mandorfer,Julie Bottero,Axel Baumgarten,Sanjay Bhagani,Karine Lacombe,Mark Nelson,Jürgen K. Rockstroh +12 more
TL;DR: The occurrence of HCV reinfection in HIV-positive men who have sex with men is an alarming incidence and prevention measures need to be addressed to address this specific subgroup of patients at high risk for HCV.
Journal ArticleDOI
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.
Christoph Wyen,Heidy Hendra,Marco Siccardi,Martin Platten,H Jaeger,Thomas Harrer,Stefan Esser,Johannes R. Bogner,Norbert H. Brockmeyer,Bernhard Bieniek,Juergen K. Rockstroh,Christian Hoffmann,Albrecht Stoehr,Claudia Michalik,Verena Dlugay,Alexander Jetter,Heribert Knechten,Hartwig Klinker,Adriane Skaletz-Rorowski,Gerd Fätkenheuer,Deirdre Egan,David Back,Andrew Owen,Stephan Dupke,Andreas Carganico,Axel Baumgarten,Siegfried Koeppe,Peter Kreckel,Elke Lauenroth-Mai,Frank Schlote,Christoph Schuler,Matthias Freiwald,Michael Rausch,Jörg Gölz,Arend Moll,Martin Zeitz,Norbert Brockmeyer,Martin Hower,Stefan Reuter,Schlomo Staszewski,Andreas Plettenberg,Stefan Fenske,Thomas Buhk,Hans-Jürgen Stellbrink,Reinhold Schmidt,Birger Kuhlmann,Franz Mosthaf,Ansgar Rieke,Stefan Scholten,Eva Jaegel-Guedes,Ramona Volkert,Werner Becker,Helmut Hartl,Antonius Mutz,Albrecht Ulmer,Bernhard Frietsch,Markus Müller +56 more
TL;DR: Genetic variability in CYP2B6 and CAR contributes to early treatment discontinuation for efavirenz-based antiretroviral regimens, and further studies are required to define the clinical utility of these associations.
Journal ArticleDOI
Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals.
Martin Vogel,Jacob Nattermann,Axel Baumgarten,Gerd Klausen,Bernhard Bieniek,Knud Schewe,Heiko Jessen,Christoph Boesecke,Michael Rausch,Thomas A. Lutz,Stefan Fenske,Dietmar Schranzo,Tim Kümmerle,Christoph Schuler,A. Theisen,Christoph Mayr,Thomas Seidel,Jürgen K. Rockstroh +17 more
TL;DR: Treatment of hepatitis C in HIV-positive individuals in the acute phase of infection leads to high rates of sustained virological response, and Peg-IFN alone showed similar treatment response rates and lower incidence of anaemia compared with peg-IFn+ribavirin combination therapy.
Journal ArticleDOI
Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases
Martin Vogel,B. Bieniek,H. Jessen,C. K. Schewe,C. Hoffmann,Axel Baumgarten,A. Kroidl,Johannes R. Bogner,Ulrich Spengler,Juergen K. Rockstroh +9 more
TL;DR: Early treatment of acute hepatitis C seems to achieve high sustained virological treatment response rates also in patients with HIV‐infection, according to a retrospective survey of HIV‐positive patients with acute HCV infection.